Life Science REIT PLC (LABS)
Category Property - Direct UK
Sell
40.00p
Buy
40.70p
0.275p (+0.69%)
Discount/Premium
-50.50%
Estimated NAV
80.812p
Prices updated at 09 May 2024, 13:23 BST
| Prices minimum 15 mins delay
Prices in GBX
Investment objective
The Company will seek to achieve its investment objective by investing in a diversified portfolio of properties across the UK which are typically leased or intended to be leased to tenants operating in, or providing a benefit to, the life science sector. Life science is the branch of sciences concerned with the study of living organisms. This encompasses the study of the breadth of life processes, and the structure and behaviour of living things. Companies operating in the life science sector include, but are not limited to, those involved in the innovation, development and/or production of assets directly or indirectly for human health purposes.
Important documents: Please ensure that you have read the Key Information Document/Technical Guide
, Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and the fund information documents. These can be found within the Charges & documents section.
- Key stats
- Price
- Performance
- Charges & documents
- Shares & trades
- Dividends
- Portfolio
- Risk
- News & dates
- Trust info
- Director info
| 40.00 | |
| Launch date | 19 Nov 2021 |
| 40.50p - 40.00p | |
| 77.40p - 37.10p | |
| 81.10 as of 31 Dec 2023 | |
| Ongoing charge audited (%) | 1.7 |
| 1.79 | |
| 0.00 | |
| 2.53 | |
| 858,983.82 | |
| 350.00m | |
| 140.00m | |
| 91.63 | |
| Semi-Annually | |
| £282.84m | |
| £276.15m | |
| -37.59 | |
| -31.25 | |
| - | |
| Fund comparative index | No benchmark |
| SA | |
| 0.77m | |
| 0.45m | |
| GB00BP5X4Q29 |
Please note that some funds may have small additional incidental charges that are not shown here. Where these charges do exist they are included within the variable ongoing costs in the Pre-sale Illustration.
